RxDoctor Payments Data

Munir Ghesani, MD

Nuclear Medicine · Princeton, NJNPI 1073506069

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 35.3% of the total.

$204,874in general payments, 2019–2025

Across 182 payments — averaging $1125.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$72K
  • Progenics Pharmaceuticals, Inc.$46K
  • Telix Pharmaceuticals$36K
  • Blue Earth Diagnostics$21K
  • Novartis$12K
  • Bayer Healthcare LLC$8K
  • plus $9K from 8 others
$39,229in research payments, 2019–2025

Across 6 payments — averaging $6538.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Blue Earth Diagnostics$33K
  • Novartis$6K

What the payments were for

  • Consulting fees$52,48226%
  • Speaking & faculty fees$64,57532%
  • Travel & lodging$81,80440%
  • Food & beverage$6,0143%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,189,841
Medicare patients
425
Services billed
2,880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →